ANGLE’s (AGL) “Corporate” Rating Reiterated at FinnCap

FinnCap reaffirmed their corporate rating on shares of ANGLE (LON:AGL) in a report released on Monday morning. FinnCap currently has a GBX 108 ($1.46) target price on the stock.

ANGLE (LON AGL) traded down GBX 0.50 ($0.01) during mid-day trading on Monday, reaching GBX 52.50 ($0.71). The company’s stock had a trading volume of 64,095 shares, compared to its average volume of 106,697. The company has a market cap of $46.54 and a PE ratio of -583.33. ANGLE has a 1 year low of GBX 32.27 ($0.44) and a 1 year high of GBX 80 ($1.08).

COPYRIGHT VIOLATION NOTICE: This story was posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at


ANGLE plc is a holding company. The Company’s principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health.

Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit